The prognostic significance of angiogenesis and the effect of vascular endothelial growth factor on angiogenic process in Wilms' tumour

Pathology

Volumn 38, Issue 5, 2006, Pages 408-414

  Ozluk, Yasemin ^a   Kilicaslan, Isin ^a   Gulluoglu, Mine G ^a   Ayan, Inci ^b   Uysal, Veli ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Angiogenesis; Prognosis; VEGF; Wilms'

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER CYTODIAGNOSIS; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CHILD; CLINICAL FEATURE; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; NEOVASCULARIZATION (PATHOLOGY); NEPHROBLASTOMA; PREDICTION; PROGNOSIS; PROTEIN EXPRESSION; SURVIVAL RATE; SURVIVAL TIME; TISSUE SECTION; TUMOR GROWTH;

ANTIGENS, CD31; ANTIGENS, CD34; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; KIDNEY; KIDNEY NEOPLASMS; MALE; MICROCIRCULATION; NEOVASCULARIZATION, PATHOLOGIC; NEPHRECTOMY; PROGNOSIS; SURVIVAL RATE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WILMS TUMOR;

EID: 33749187067     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020600922926     Document Type: Article

References (41)

1. Argani P, Beckwith JB. Renal neoplasms of childhood. In: Mills SE, Carter D, Greenson JK, Oberman HA, Reuter V, Stoler MH, editors. Diagnostic Surgical Pathology. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2004; 2001-33.
2. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor: results of the third National Wilms' Tumor Study. Cancer 1989; 64: 349-60.
3. Breslow NG, Beckwith JB, Ciol M, Sharples K. Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Res 1988; 48: 1653-7.
4. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor: a descriptive study. Med Pediatr Oncol 1996; 27: 398-403.
5. Beckwith JB. Tumors of infancy and childhood. In: Murphy WM, Beckwith JB, Farrow GM, editors. Tumors of the Kidney, Bladder, and Related Urinary Structures. Atlas of Tumor Pathology. 3rd series, Fascicle 11. Washington DC: Armed Forces Institute of Pathology, 1994; 12-91.
6. Zuppan CW, Beckwith JB, Luckey DW. Anaplasia in unilateral Wilms' tumor: a report from the National Wilms' Tumor Study Pathology Center. Hum Pathol 1988; 19: 1199-209.
7. Pinkerton CR, Groot-Loonen JJ, Morris-Jones PH. Response rates in relapsed Wilms' tumor. Cancer 1991; 67: 567-71.
8. Weeks DA, Beckwith JB, Luckey DW. Relapse-associated variables in Stage I favorable histology Wilms' tumor: a report of the National Wilms' Tumor Study. Cancer 1987; 60: 1204-12.
9. Sköldenberg EG, Christiansson J, Sandstedt B, et al. Angiogenesis and angiogenic growth factors in Wilms tumor. J Urol 2001; 165: 2274-9.
10. Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue? G H A Clowes Memorial Award Lecture. Cancer Res 1986; 46: 467-73.
11. Kim E, Moore J, Huang J, et al. All angiogenesis is not the same: distinct patterns of response to antiangiogenic therapy in experimental neuroblastroma and Wilms tumor. J Pediatr Surg 2001; 36: 287-90.
12. Rowe DH, Huang J, Kayton ML, et al. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms tumor. J Pediatr Surg 2000; 35: 30-3.
13. Kaku T, Kamura T, Kinukawa N, et al. Angiogenesis in endometrial carcinoma. Cancer 1997; 80: 741-7.
14. Maeda K, Chung Y, Takatsuka S, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995; 13: 477-81.
15. Tanigawa N, Matsamura M, Amaya H, et al. Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 1997; 79: 220-5.
16. Inoue K, Ozeki Y, Suganuma T, et al. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: association with angiogenesis and tumor progression. Cancer 1997; 79: 206-13.
17. Tas F, Yavuz E, Aydiner A, et al. Angiogenesis and p53 protein expression in breast cancer. Am J Clin Oncol 2000; 23: 546-53.
18. Salven P, Lymboussaki A, Heikkilä P, et al. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors. Am J Pathol 1998; 153: 103-8.
19. Lee AHS, Dublin EA, Bobrow LG, Poulsom R. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis. J Pathol 1998; 185: 394-401.
20. Lee JS, Kim HS, Jung JJ, et al. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression. J Surg Oncol 2001; 77: 55-60.
21. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995; 55: 3964-8.
22. Rowe DH, Kayton ML, O'Toole KM, et al. Pathological angiogenesis in a murine model of human Wilms' tumor. J Pediatr Surg 1999; 34: 676-9.
23. Kayton ML, Rowe DH, O'Toole M, et al. Metastasis correlates with production of vascular endothelial growth factor in a murine model of human Wilms' tumor. J Pediatr Surg 1999; 34: 743-8.
24. Karth J, Ferrer FA, Perlman E, et al. Coexpression of hypoxiainducable factor 1-alpha and vascular endothelial growth factor in Wilms' tumor. J Pediatr Surg 2000; 35: 1749-53.
25. Huang J, Moore J, Soffer S, et al. Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors. J Pediatr Surg 2001; 36: 357-61.
26. Soffer SZ, Moore JT, Kim E, et al. Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor. J Pediatr Surg 2001; 36: 1177-81.
27. D'Angio GJ, Evans A, Breslow N, et al. The teratment of Wilms tumor: results of the Second National Wilms' Tumor Study. Cancer 1981; 47: 2302-11.
28. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms tumor: results of the Third National Wilms Tumor Study. Cancer 1989; 64: 349-60.
29. Green DM, Breslow NE, Beckwith JB, et al. Effect of duration of treatment on treatment outcome and cost of treatment for Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 1998; 16: 3744-51.
30. Faria P, Beckwith JB, Mishra K, et al. Focal and diffuse anaplasia in Wilms tumor - new definitions with prognostic significance: a report from the National Wilms Tumor Study group. Am J Surg Pathol 1996; 20: 909-20.
31. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
32. Abramson LP, Grundy PE, Rademaker AW, et al. Increased microvascular density predicts relapse in Wilms' tumor. J Pediatr Surg 2003; 38: 325-30.
33. Salvesen HB, Gulluoglu MG, Stefansson I, Akslen LA. Significance of CD105 expression for tumour angiogenesis and prognosis in endometrial carcinomas. APMIS 2003; 111: 1011-8.
34. Mineo TC, Ambrogi T, Baldi A, et al. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIa non-small cell lung cancer. J Clin Pathol 2004; 57: 591-7.
35. Vieira SC, Zeferino LC, da Silva BB, et al. Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers. Gynecol Oncol 2004; 93: 121-4.
36. Uzzan B, Nicolas P, Cucherat M, Perret G-Y. Microvessel density as a prognostic factor in women with breast carcinoma: a systematic review of the literature and meta-analysis. Cancer Res 2004; 64: 2941-55.
37. Folkman J. Tumor angiogenesis. In: Mendelson J, Howley PM, Israel MA, Liotta LA, editors. The Molecular Basis of Cancer. Philadelphia: WB Saunders Company, 1995; 206-32.
38. Seki N, Kodama J, Hongo A, et al. Vascular endothelial growth factor and platelet-derived endothelial growth factor expression are implicated in the angiogenesis of endometrial cancer. Eur J Cancer 2000; 36: 68-73.
39. Frischer JS, Huang J, Serrur A, et al. Effects of potent VEGF blockade on experimental Wilms' tumor and its persisting vasculature. Int J Oncol 2004; 25: 549-53.
40. Ghanem MA, van Steenbrugge GJ, Sudaryo MK, et al. Expression and prognostic relevance of vascular endothelial growth factor (VEGF) and its receptor (FLT-1) in nephroblastoma. J Clin Pathol 2003; 56: 107-13.
41. Miller K. Immunocytochemical techniques. In: Bancroft JD, Gamble M, editors. Theory and Practice of Histological Techniques. 5th ed. Edinburgh: Chuchill Livingstone, 2002; 421-63.